Acuta Capital Partners’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-205,377
| Closed | -$7.13M | – | 54 |
|
|
2023
Q3 | $7.13M | Buy |
205,377
+58,059
| +39% | +$2.02M | 4.78% | 7 |
|
|
2023
Q2 | $4.83M | Sell |
147,318
-61,182
| -29% | -$2.01M | 3.27% | 13 |
|
|
2023
Q1 | $6.98M | Sell |
208,500
-82,000
| -28% | -$2.75M | 5.15% | 5 |
|
|
2022
Q4 | $7.56M | Buy |
290,500
+110,500
| +61% | +$2.87M | 4.65% | 9 |
|
|
2022
Q3 | $6.28M | Buy |
180,000
+58,000
| +48% | +$2.02M | 2.71% | 13 |
|
|
2022
Q2 | $1.49M | Buy |
122,000
+51,123
| +72% | +$625K | 0.83% | 31 |
|
|
2022
Q1 | $962K | Buy |
+70,877
| New | +$962K | 0.45% | 32 |
|